Farmanews.com

Notas de Prensa  

23 de enero de 2003

On an Adjusted Basis, Amgen Reports Fourth Quarter Earnings Per Share Increase 17 Percent to 35 Cents, Full Year 2002 Increase 18 Percent to $1.39

On a GAAP Basis, Fourth Quarter Earnings Per Share Were 34 Cents; With a Full Year 2002 Loss Per Share of $1.21 Primarily Due to the $3 Billion One-Time Write-Off of Acquired In-Process R&D Fourth Quarter Product Sales Increase 66 Percent Aranesp(R) Sales Reach $207 Million in the Fourth Quarter Neulasta(TM) Sales Reach $212 Million in the Fourth Quarter ENBREL(R) Sales Achieve $204 Million in the Fourth Quarter

Subir  

Subir notas de prensa y convocatorias

Próximas convocatorias   

No hay próximas convocatorias
Ver todas

Especialidades  

Busca notas de prensa por especialidad médica o enfermedad.



Ver todas

Archivo  

Busca notas de prensa por su fecha de edición.

  Selecciona el año


Copyright © 2017, Farmavet, S.L. Todos los derechos reservados.